Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 5, 2009, Pages 731-735

  Sofi, Francesco ^a,b   Cesari, F ^a   Tu, Y ^c   Pratesi, G ^a   Pulli, R ^a   Pratesi, C ^a   Gensini, G F ^b   Abbate, R ^a   Broze Jr , G J ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Peripheral arterial disease; Protein; Z; ZPI

Indexed keywords

BLOOD CLOTTING FACTOR 10; FATTY ACID BINDING PROTEIN; SERINE PROTEINASE INHIBITOR; VITAMIN K GROUP;

ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENDER; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; SERPINS;

EID: 65349096879     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03325.x     Document Type: Article

References (37)

1. Broze GJ Jr, Miletich JP. Human protein Z. J Clin Invest 1984; 73: 933-8.
2. Han X, Fiehler R, Broze GJ Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998; 95: 9250-5.
3. Huang X, Swanson R, Broze GJ Jr, Olson ST. Kinetic characterization of the protein Z-dependent protease inhibitor (ZPI) reaction with blood coagulation factor Xa. J Biol Chem 2008; 283: 29770-83.
4. Tabatabai A, Fiehler R, Broze GJ Jr. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost 2001; 85: 655-60.
5. Martinelli I, Razzari E, Bucciarelli P, Mannucci PM. Low levels of protein Z and the risk of venous thromboembolism. J Thromb Haemost 2005; 3: 2817-19.
6. Kemkes-Matthes B, Nees M, Kuhnel G, Matzdorff A, Matthes KJ. Protein Z influences the prothrombotic phenotype of factor V Leiden in humans. Thromb Res 2002; 106: 183-5.
7. Vasse M, Guegan-Massardier E, Borg J-Y, Woimant F, Soria C. High frequency of protein Z deficiency in patients with ischemic stroke. Lancet 2001; 357: 933-4.
8. Heeb M, Paganini-Hill A, Griffin J, Fisher M. Low protein Z levels and risk of ischemic stroke; differences by diabetic status and gender. Blood Cells Mol Dis 2002; 29: 139-44.
9. Santacroce R, Sarno M, Cappucci F, Sessa F, Colaizzo D, Brancaccio V, Grandone E, Margaglione M. Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost 2006; 4: 2417-22.
10. Lopaciuk S, Bykowska K, Kwiecinski H, Czlonkowska A, Kuczynska-Zardzewialy A. Protein Z in young survivors of ischemic stroke. Thromb Haemost 2002; 88: 536.
11. McQuillan A, Eikelboom J, Hankey G, Baker R, Thom J, Staton J, Yi Q, Cole V. Protein Z in ischemic stroke and its etiologic subtypes. Stroke 2003; 34: 2415-19.
12. Morange PE, Juhan-Vague I, the PRIME study group. Protein Z plasma levels are not associated with the risk of coronary heart disease: The PRIME study. J Thromb Haemost 2004; 2: 2050-1.
13. Al-Shanqeeti A, van Hycklama A, Berntorp E, Rosendaal FR, Broze GJ Jr. Protein Z and protein Z-dependent protease inhibitor: Determinants of levels and risk of venous thrombosis. Thromb Haemost 2006; 93: 411-13.
14. Refaai MA, Ahn C, Lu L, Wu K, Broze GJ Jr. Protein Z and ZPI levels and cardiovascular events. J Thromb Haemost 2006; 4: 1628-9.
15. van de Water N, Tan T, Ashton F, O'Grady A, Day T, Browett P, Ockelford P, Harper P. Mutations within the protein Z-dependent protease inhibitor gene are associated with venous thromboembolic disease: A new form of thrombophilia. Br J Haematol 2004; 127: 190-4.
16. Corral J, Gonzalez-Conejero R, Soria JM, Gonzalez-Porras JR, Perez-Ceballos E, Lecumberri R, Roldan V, Souto JC, Minano A, Hernandez-Espinosa D, Alberca I, Fontcuberta J, Vicente V. A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thromboembolism. Blood 2006; 108: 177-83.
17. Razzari C, Marinelli I, Bucciarelli P, Viscardi Y, Biguzzi E. Polymorphisms of the protein Z-dependent protease inhibitor (ZPI) gene and the risk of venous thromboembolism. Thromb Haemost 2006; 95: 909-10.
18. Folsom AR, Cushman M, Rasmussen-Torvik LJ, Heckbert SR, Tsai MY. Prospective study of polymorphisms of the protein Z-dependent protease inhibitor and risk of venous thromboembolism. Thromb Haemost 2007; 97: 493-4.
19. Fedi S, Sofi F, Brogi D, Tellini I, Cesari F, Sestini I, Gazzini A, Comeglio M, Abbate R, Gensini GF. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost 2003; 90: 1173-8.
20. Sofi F, Cesari F, Vigiani S, Fatini C, Marcucci R, Giglioli C, Valente S, Abbate R, Gensini GF, Fedi S. Protein Z plasma levels in different phases of activity of coronary atherosclerosis. J Thromb Haemost 2005; 3: 2254-8.
21. Sofi F, Cesari F, Pratesi G, Cellai AP, Pulli R, Pratesi C, Gensini GF, Abbate R, Fedi S. Low protein Z levels in patients with peripheral arterial disease. Thromb Haemost 2007; 98: 1114-17.
22. Zhang J, Tu Y, Lu L, Lasky N, Broze GJ Jr. Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency. Blood 2008; 111: 4973-8.
23. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, Crouse JR 3rd, Friedman L, Fuster V, Herrington DM, Kuller LH, Ridker PM, Roberts WC, Stanford W, Stone N, Swan HJ, Taubert KA, Wexler L. Prevention Conference VI Beyond secondary prevention: identifying the high-risk patient for primary prevention: Non-invasive tests of atherosclerosis burden. Writing Group III. Circulation 2000; 101: E16-22.
24. Sofi F, Vecchio S, Giuliani G, Martinelli F, Marcucci R, Gori AM, Fedi S, Casini A, Surrenti C, Abbate R, Gensini GF. Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: The 'Florence' diet is not Mediterranean. Eur J Clin Nutr 2005; 59: 584-91.
25. Cifokova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, Kjeldsen S, Luscher T, Mallion JM, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, van Zwieten P, Waeber B, Williams B, Zanchetti A. ESH/ ESC Hypertension Guidelines Committee. J Hypertension 2003; 21: 1779-86.
26. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
27. Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-20.
28. Rezaie AR, Sun M, Gailani D. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity. Biochemistry 2006; 45: 9427-33.
29. Greten J, Kreis I, Liliensiek B, Allenberg J, Amiral J, Ziegler R, Nawroth PP. Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa 1998; 27: 144-8.
30. De Buyzere M, Philippe J, Duprez D, Baele G, Clement DL. Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease. Am J Hematol 1993;43: 91-4.
31. Reininger CB, Graf J, Reininger A, Spannagi M, Steckmeier B, Schweiberer L. Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease. Thromb Res 1996; 82: 523-32.
32. Han X, Fiehler R, Broze GJ Jr. Characterization of the protein Z-dependent protease inhibitor. Blood 2000; 96: 3049-55.
33. Brevetti G, Schiano V, Chiariello M. Endothelial dysfunction: A key to the pathophysiology and natural history of peripheral arterial disease. Atherosclerosis 2008; 197: 1-11.
34. Vasse M, Denoyelle C, Corbiere C, Litzler PY, Legrand E, Vannier JP. Human endothelial cells synthesize protein Z, but not the protein Z dependent inhibitor. Thromb Haemost 2006; 95: 519-23.
35. Cesari F, Gori AM, Fedi S, Abbate R, Gensini GF, Sofi F. Modifications of protein Z and interleukin-6 during the acute phase of coronary artery disease. Blood Coagul Fibrinolysis 2007; 18: 85-6.
36. Ramsay JE, Stewart F, Friel H, Walker ID, Greer A, McColl MD. Protein Z in pregnancy: Exaggerated rise in obese women. J Thromb Haemost 2005; 3: 2584-6.
37. van Goor MPJ, Dippel DWJ, Jie KS-G, de Maat MPM, Koudstaal PJ, Leebeek FWG. Low protein Z levels, but not the protein Z gene G79A polymorphism are a risk factor for ischemic stroke. Thromb Res 2008; 123: 213-18.